
Larazotide Acetate
Tight junction peptide that supports gut barrier integrity and reduces intestinal permeability.
Larazotide Acetate
Larazotide Acetate is a synthetic octapeptide that regulates tight junction assembly and function in intestinal epithelial cells. It was developed to support intestinal permeability, the zonulin pathway, and the role of tight junction regulation in gut health. Its ability to modulate paracellular permeability makes it a targeted tool for gut barrier support.
How It Works
Larazotide Acetate's primary mechanism involves regulation of tight junction proteins and the zonulin signaling pathway:
• Tight Junction Stabilization:: Promotes the assembly and stability of tight junction complexes, increasing the expression and proper localization of occludin, claudin-1, and ZO-1
• Zonulin Pathway Modulation:: Antagonizes zonulin-mediated tight junction opening, reducing paracellular permeability
• Gut Barrier Integrity:: Reduces transepithelial electrical resistance (TEER) loss and paracellular flux of macromolecules
• Anti-Inflammatory:: Modulates inflammatory cytokine production in intestinal epithelial cells
• Actin Cytoskeleton Support:: Supports perijunctional actin organization at cell-cell junctions
Key Benefits
• Gut Barrier Support:: Strengthens intestinal tight junctions to reduce "leaky gut"
• Permeability Reduction:: Reduces paracellular permeability and macromolecule flux
• Gut Inflammation:: Modulates intestinal inflammatory cytokine production
• Digestive Wellness:: Supports overall gut health and intestinal barrier function
Structural Properties
Larazotide Acetate has a molecular weight of 1046.1 Da (CAS: 485832-18-6). An octapeptide with acetate salt form for improved solubility. Purity ≥98.0%.
Quality and Purity
Supplied as a lyophilized powder with purity ≥98.0% verified by HPLC and mass spectrometry. Each vial contains 10 mg.
Storage
Store at −20°C. Stable for 24 months.
Product Details
Storage & Handling
Store at -20°C.
Related Products

KPV Tripeptide
α-MSH derivative that modulates NF-κB to reduce inflammation and support healing.

VIP (Vasoactive Intestinal Peptide)
Neuropeptide that modulates immune response and reduces chronic inflammation.